Update on geriatric cardiology;Actualización en cardiología geriátrica

Revista Espanola de Cardiologia

Volumn 61, Issue SUPPL. 1, 2008, Pages 4-14

  Martínez Sellés, Manuel ^a   Datino, Tomás ^a   Gómez Sánchez, Miguel A ^b   Bañuelos, Camino ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Elderly; Geriatric cardiology; Heart disease

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; PRAVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; AORTA STENOSIS; AORTA SURGERY; BLEEDING; CARDIOVASCULAR DISEASE; CONSENSUS; DEFIBRILLATOR; GERIATRIC CARE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MITRAL VALVE; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY HYPERTENSION; REVIEW; VALVULAR HEART DISEASE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CARDIOLOGY; GERIATRICS; HEART DISEASES; HEART VALVE DISEASES; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 46449128824     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2570-89.
2. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115: 2549-69.
3. Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK; Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med. 2007;147:1-9.
4. Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, et al. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation. 2007;115:700-7.
5. Choudhry NK, Levin R, Winkelmayer WC. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart. 2007;93:945-51.
6. American Heart Association. Older Americans and cardiovascular diseases-statistics [accedido 28 Jul 2007]. Disponible en: http://www. americanheart.org/presenter.jhtml?identifier=3000936.
7. Martínez-Selles M, López-Palop R, Pérez-David E, Bueno H. Influence of age on gender differences in the management of acute inferior or posterior myocardial infarction. Chest. 2005;128:792-7.
8. Nacional Registry of Myocardial Infarction [accedido 28 Jul 2007]. Disponible en: http://www.nrmi.org
9. Skolnick AH, Alexander KP, Chen AY, Roe MT, Pollack CV Jr, Ohman EM, et al. Characteristics, management, and outcomes of 5,557 patients age ≥ 90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol. 2007;49:1790-7.
10. Heras M, Bueno H, Bardají A, Fernández-Ortiz A, Martí H, Marrugat J; DESCARTES Investigators. Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry. Heart. 2006;92:1571-6.
11. Hernández AV, Westerhout CM, Steyerberg EW, Ioannidis JP, Bueno H, White H, et al. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups. Heart. 2007;93:450-5.
12. Martinez-Selles M, Datino T, Bueno H. Coronary care unit admission of very old patients with acute myocardial infarction. Heart. 2006;92:549-50.
13. Martínez-Selles M, Datino T, Bueno H. Influence of reperfusion therapy on prognosis in patients aged ≥ 89 years with acute myocardial infarction. Am J Cardiol. 2005;95:1232-4.
14. Bardají A, Bueno H, Fernández-Ortiz A, Cequier A, Augé JM, Heras M. Tratamiento y evolución a corto plazo de los ancianos con infarto agudo de miocardio ingresados en hospitales con disponibilidad de angioplastia primaria. El Registro TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos). Rev Esp Cardiol. 2005;58:351-8.
15. Bueno H, Martínez-Selles M, Pérez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J. 2005;26:1705-11.
16. Leone A. Causes of death from myocardial infarction before and after thrombolysis era: a pathologic study. Singapore Med J. 1996;37:270-2.
17. Martinez-Selles M, Barrio JM, Hortal J, Ruiz M, Bueno H. Prevalence of peripheral arterial disease and prior stroke in octogenarians with symptomatic severe aortic stenosis or severe coronary artery disease: influence in management and outcome. Int Angiol. 2007;26:33-7.
18. Basaran M, Selimoglu O, Ozcan H, Ogus H, Kafali E, Ozcelebi C, et al. Being an elderly woman: is it a risk factor for morbidity after coronary artery bypass surgery? Eur J Cardiothorac Surg. 2007;32:58-64.
19. Martinez-Selles M, Hortal J, Barrio JM, Ruiz M, Bueno H. Treatment and outcomes of severe cardiac disease with surgical indication in very old patients. Int J Cardiol. 2007;119:15-20.
20. Nisanoglu V, Erdil N, Aldemir M, Ozgur B, Berat Cihan H, Yologlu S, et al. Atrial fibrillation after coronary artery bypass grafting in elderly patients: incidence and risk factor analysis. Thorac Cardiovasc Surg. 2007;55:32-8.
21. Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, et al; PROSPER Study Group. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation. 2007;115:981-9
22. Olsson AG, Schwartz GG, Szarek M, Luo D, Jamieson MJ. Effects of high-dose atorvastatin in patients ≥ 65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with agressive cholesterol lowering [MIRACL] study). Am J Cardiol. 2007;99:632-5.
23. Berger AK, Duval SJ, Armstrong C, Jacobs DR, Luepker RV. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study. Am J Geriatr Cardiol. 2007;16:15-23.
24. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-5.
25. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
26. Cea-Calvo L , Redón J, Lozano JV, Fernández-Pérez C, Martí-Canales JC, Llisterri JL, et al, en representación de los investigadores del estudio PREV-ICTUS. Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS. Rev Esp Cardiol. 2007;60:616-24.
27. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-57.
28. Fuster V, Ryden LE, Cannom DS, Crijins HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC: Guía de práctica clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida. Rev Esp Cardiol. 2006;59:1329.e1-64.
29. Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing. 2007;36:151-6.
30. Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumadle J, Salvador A, et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. A randomized study. J Am Coll Cardiol. 2004;44:1557-66.
31. Pérez-Gómez F, Iriarte JA, Zumalde J, Berjón J, Salvador A, Alegría E, et al. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. Eur Heart J. 2007;28:996-1003.
32. Mant JW, Richards SH, Hobbs FD, Fitzmaurice D, Lip GY, Murray E, et al. Protocol for Birmingham atrial fibrillation treatment of the aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population. BMC Cardiovasc Disord. 2003;3:9.
33. Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, et al. Age and the risk of warfarin associated hemorrhage: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. J Am Geriatr Soc. 2006;54:1231-6.
34. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689-96.
35. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151:713-9.
36. Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130:1390-6.
37. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-33.
38. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-40.
39. Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, et al. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol. 2006;48:721-30.
40. Martínez-Brotóns AM, Ruiz-Granell R, Morell S, Plancha E, Ferrero A, Roselló A, et al. Rendimiento terapéutico de un protocolo prospectivo de cardioversión en la fibrilación auricular persistente. Rev Esp Cardiol. 2006;59:1038-46.
41. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043-51.
42. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000;101:1403-8.
43. Magee MJ, Herbert MA, Dewey TM, Edgerton JR, Ryan WH, MD, Prince S, et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg. 2007;83:1707-12.
44. Myerburg RJ, Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm. 2006;3:235-9.
45. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003;24:13-5.
46. Holmberg M, Holmberg S, Herlitz J. Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation. 2000;44:7-17.
47. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita. Versión resumida. Rev Esp Cardiol. 2006;59:1328.e1-51.
48. Lee DS, Tu JV, Austin PC, Liu PP, Naimark D, Tu JV, et al. Effect of cardiac and noncardiac conditions on survival after defribrillator implantation. J Am Coll Cardiol. 2007;49:2408-15.
49. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, et al; for the MADIT-II Research Group. Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy. J Cardiovasc Electrophysiol. 2007;18:833-8.
50. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007;28:1746-9.
51. Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest. 2007;131:94-100.
52. Hyduk AB, Croft J, Ayala C, Zheng K, Zheng Z. Pulmonary Hypertension Surveillance United States, 1980-2002. Division for Heart Disease and Stroke Prevention National Center for Chronic Disease Prevention and Health Promotion MMWR Surveill Summ. 2005;54:1-28.
53. Kjaergaard J, Akkan D, Iversen KK, Kjoller E, Køber L, Torp-Pedersen C, et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol. 2007;99:1146-50.
54. Martinez-Selles M, Munoa MD, Martinez E, Fernández MA, García E. The influence of sex on right ventricular dysfunction in patients with severely depressed left ventricular ejection fraction. Eur J Heart Fail. 2006;8:400-3.
55. Okura Y, Ohno Y, Ramadan MM, Suzuki K, Taneda K, Obata H, et al. Characterization of outpatients with isolated diastolic dysfunction and evaluation of the burden in a Japanese community: Sado Heart Failure Study. Circ J. 2007;71:1013-21.
56. Otero-Raviña F, Grigorian-Shamagian L, Fransi-Galiana L, Názara-Otero C, Fernández-Villaverde JM, Del Alamo-Alonso A, et al. Grupo de Investigadores GALICAP. Estudio gallego de insuficiencia cardiaca en atención primaria (estudio GALICAP). Rev Esp Cardiol. 2007;60:373-83.
57. Bouchard JL, Aurigemma GP, Goldberg RJ, Fournier JB, Vinch CS, Hill JC, et al. Heart failure in the «oldest old»: clinical and echocardiographic insights. Am J Geriatr Cardiol. 2007;16:236-42.
58. Dobre D, Van Veldhuisen DJ, Mordenti G, Vintila M, Haaijer-Ruskamp FM, Coats AJ, et al. SENIORS Investigators Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. Am Heart J. 2007;154:109-15.
59. Martinez-Selles M, Dominguez M, Martinez E, Garcia Fernandez MA, Garcia E. Statin use and prognosis in patients with advanced heart failure. Int J Cardiol. 2007;118:135-7.
60. Achilli A, Turreni F, Gasparini M, Lunati M, Sassara M, Santini M, Landolina M, et al, on behalf of the InSync/InSync ICD Italian Registry Investigators. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry. EuroPace. 2007;9:732-8.
61. Martinez-Selles M, Dominguez M, Martinez E, Garcia Fernandez MA, Garcia E. Women with left ventricular ejection fraction ≤ 20% have better prognosis than men. Int J Cardiol. 2007;120:276-8.
62. Forni A, Faggian G, Chiominto B, Iafrancesco M, Patelli F, Innocente F, et al. Heart transplantation in older candidates. Transplant Proc. 2007;39:1963-6.
63. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. Guidelines for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2006;48:e1-148.
64. Cribier A, Savin T, Saondi N, Rocha P, Berland J, Letac B . Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve remplacement? Lancet. 1986;1:63-8.
65. Bañuelos C, Macaya C, Iñiguez A, et al. Valvuloplastia aórtica en el anciano. Rev Esp Geriatr Gerontol. 1989; 24:398-400.
66. Otto CM, Mickel MC, Kennedy JW, Alderman EL, Bashore TM, Blak PC, et al. Three years outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89:642-50.
67. Hernandez-Antolin R, Bañuelos C, Macaya C. Tratamiento invasivo de las valvulopatías. Monocardio. 2000;4:266-85.
68. Bañuelos C. Tratamiento de la estenosis aórtica en el anciano. Alternativas no quirúrgicas. Rev Esp Geriatr Gerontol. 2002;37:40-4.
69. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckz J, Yacine A, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-5.
70. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-8.
71. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B, et al. First report on a human percutaneous transluminal implantation of a self expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovas Interv. 2005;66:465-9.
72. Paniagua D, Condado JA, Besso J, Velez M, Burger B, Bibbo S, et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J. 2005;32:393-8.
73. Webb JC, Pasupati S, Humphries K, Thompson Ch, Atwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high risk patients with aortic stenosis. Circulation. 2007;116:755-63.
74. Lichtenstein SV, Cheung A, Ye J, Thompson ChR, Carere RG, Pasupati S, et al. Transapical transcatheter aortic valve implantation in humans. Initial clinical experience. Circulation. 2006;114:591-6.
75. Walther Th, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation. Multicenter experience. Circulation. 2007;116 Suppl I:I240-5.
76. Walther Th, Mohr FW. Aortic valve surgery: time to open-minded and to rethink. Eur J Cardiothorac Surg. 2007;31:4-6.
77. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thoracic Surg. 2001;122:674-81.
78. Condado JA, Acquatella H, Rodriguez L, Whitlow P, Velez M, St Goar F. Percutaneous edge-to-edge mitral valve repair: 2 years follow up in the first human case. Catheter Cardiovasc Interv. 2006;67:323-5.
79. Feldman T, Wasserman HS, Herrman HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six month results of the EVEREST phase I clinical trial. J Am Coll Cardiol. 2005;46:2134-40.
80. Condado JA, Burger B. Tratamiento percutáneo de las válvulas cardiacas. Rev Esp Cardiol. 2006;59:1225-31.
81. Webb JG, Harnec J, Munt BI, Kimbald PO, Chandavimol M, Thompson CR, et al. Percutaneous transvenous mitral annuloplasty initial human experience with device implantation in the coronary sinus. Circulation. 2006;113:851-5.
82. Maselli D, Guarracino F, Chiaramondi F, Mangia F, Berelli G, Minzioni G. Percutaneous mitral annuloplasty: anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114:337-80.